Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tami L Mark

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Psychiatric Services (Washington, D.C.)|January 17, 2018
The Extent to Which Psychiatrists Diagnose and Treat Substance Use DisordersTami L Mark, Angélica Meinhofer
Psychiatric Services (Washington, D.C.)|September 3, 2014
Follow-up encounters within 30 days of a substance abuse-related inpatient dischargeMark W Smith, Tami L Mark
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost-effectiveness of epoetin alfa and darbepoetin alfa in patients with chemotherapy-related anemiaMei Sheng Duh, Tami L Mark
Health Affairs (Project Hope)|January 17, 2003
What drove private health insurance spending on mental health and substance abuse care, 1992-1999?Tami L Mark, Rosanna M Coffey
Drug and Alcohol Dependence|March 23, 2012
Spending trends on substance abuse treatment under private employer-sponsored insurance, 2001-2009Tami L Mark, Rita Vandivort-Warren
JAMA Network Open|March 24, 2022
Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 PandemicWilliam N Dowd, Tami L Mark
Psychiatric Services (Washington, D.C.)|January 10, 2006
Datapoints: State-administered spending on mental health services by type of serviceJeffrey A Buck, Tami L Mark
JAMA Health Forum|December 6, 2024
Drug Overdose Deaths Among Medicaid BeneficiariesTami L Mark, Benjamin D Huber
Health Affairs (Project Hope)|November 13, 2004
The decline in receipt of substance abuse treatment by the privately insured, 1992-2001Tami L Mark, Rosanna M Coffey
Psychiatric Services (Washington, D.C.)|June 9, 2005
Components of spending for Medicaid Mental Health Services, 2001Tami L Mark, Jeffrey A Buck
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Psychiatric Services (Washington, D.C.)|January 17, 2018
The Extent to Which Psychiatrists Diagnose and Treat Substance Use DisordersTami L Mark, Angélica Meinhofer
Psychiatric Services (Washington, D.C.)|September 3, 2014
Follow-up encounters within 30 days of a substance abuse-related inpatient dischargeMark W Smith, Tami L Mark
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost-effectiveness of epoetin alfa and darbepoetin alfa in patients with chemotherapy-related anemiaMei Sheng Duh, Tami L Mark
Health Affairs (Project Hope)|January 17, 2003
What drove private health insurance spending on mental health and substance abuse care, 1992-1999?Tami L Mark, Rosanna M Coffey
Drug and Alcohol Dependence|March 23, 2012
Spending trends on substance abuse treatment under private employer-sponsored insurance, 2001-2009Tami L Mark, Rita Vandivort-Warren
JAMA Network Open|March 24, 2022
Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 PandemicWilliam N Dowd, Tami L Mark
Psychiatric Services (Washington, D.C.)|January 10, 2006
Datapoints: State-administered spending on mental health services by type of serviceJeffrey A Buck, Tami L Mark
JAMA Health Forum|December 6, 2024
Drug Overdose Deaths Among Medicaid BeneficiariesTami L Mark, Benjamin D Huber
Health Affairs (Project Hope)|November 13, 2004
The decline in receipt of substance abuse treatment by the privately insured, 1992-2001Tami L Mark, Rosanna M Coffey
Psychiatric Services (Washington, D.C.)|June 9, 2005
Components of spending for Medicaid Mental Health Services, 2001Tami L Mark, Jeffrey A Buck
Pageof 13